Finances
Olezarsen Reduces Triglyceride Levels in sHTG
Triglyceride Reduction is a critical area of focus in managing severe hypertriglyceridemia (sHTG), a condition that significantly increases the risk of acute pancreatitis and cardiovascular diseases. Recent clinical trials, specifically the CORE and CORE2 studies, have highlighted the efficacy of olezarsen in achieving remarkable reductions in fasting triglyceride levels. This Read more…